Your browser doesn't support javascript.
loading
TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
Shirai, Kiyokazu; Nagae, Genta; Seki, Motoaki; Kudo, Yotaro; Kamio, Asuka; Hayashi, Akimasa; Okabe, Atsushi; Ota, Satoshi; Tsutsumi, Shuichi; Fujita, Takanori; Yamamoto, Shogo; Nakaki, Ryo; Kanki, Yasuharu; Osawa, Tsuyoshi; Midorikawa, Yutaka; Tateishi, Keisuke; Ichinose, Masao; Aburatani, Hiroyuki.
Afiliación
  • Shirai K; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Nagae G; Department of Gastroenterology, Wakayama Medical University, Wakayama, Japan.
  • Seki M; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Kudo Y; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Kamio A; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Hayashi A; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Okabe A; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Ota S; Laboratory of Genetics, Department of Biological Sciences, The University of Tokyo, Tokyo, Japan.
  • Tsutsumi S; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Fujita T; Department of Pathology, Kyorin University Faculty of Medicine, Mitaka, Japan.
  • Yamamoto S; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Nakaki R; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kanki Y; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Osawa T; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Midorikawa Y; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Tateishi K; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Ichinose M; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Aburatani H; Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Cancer Sci ; 112(7): 2855-2869, 2021 Jul.
Article en En | MEDLINE | ID: mdl-33970549
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Proteína HMGA2 / Oxigenasas de Función Mixta / Neoplasias Hepáticas / Proteínas de Neoplasias Límite: Humans Idioma: En Revista: Cancer Sci Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Proteína HMGA2 / Oxigenasas de Función Mixta / Neoplasias Hepáticas / Proteínas de Neoplasias Límite: Humans Idioma: En Revista: Cancer Sci Año: 2021 Tipo del documento: Article País de afiliación: Japón